IRIS
MARCENARO, EMANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.681
Totale 15.681
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.681
Totale 15.681
Salva come PNG Salva come JPEG
Città #
Genova 11.514
Rapallo 1.653
Genoa 1.503
Vado Ligure 960
Bordighera 51
Totale 15.681
Salva come PNG Salva come JPEG
Nome #
Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. 168
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 167
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 160
NK/DC crosstalk in anti-viral response. 159
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 154
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 152
Markers and function of human NK cells in normal and pathological conditions 147
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 145
NK cells and their receptors during viral infections. 143
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 142
2B4 functions as a co-receptor in human NK cell activation 141
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. 141
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 141
Bridging innate NK cell Functions with Adaptive Immunity. 137
Role of the 2B4 receptor in CD8+ T-cell-dependent immune control of Epstein-Barr virus infection in mice with reconstituted human immune system components 135
Multi-directional cross-regulation of NK cell function during innate immune responses. 135
Features of Memory-Like and PD-1+ Human NK Cell Subsets 134
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 131
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells 129
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 129
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 129
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma 128
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 127
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 126
Pathogen-induced private conversations between natural killer and dendritic cells 125
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 125
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 125
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation 124
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 123
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 123
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway 122
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 121
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. 119
Natural killer lymphocytes: "null cells" no more. 119
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy 118
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 118
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 117
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues 117
Identification of NKG2A and NKp80 as specific Natural Killer cell markers in rhesus and pigtailed monkeys 116
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 116
Harnessing NK Cells for Cancer Treatment 116
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 115
Human NK cell response to pathogens 114
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 113
Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity 112
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 112
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 112
Natural killer cell-triggering receptors in patients with acute leukaemia. 111
Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways 110
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 110
TLR/NCR/KIR: Which One to Use and When? 109
Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis 109
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 108
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 107
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 107
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 107
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer cell subsets associated with high levels of HIV-1 viremia. 106
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 106
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 106
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML 106
Human Natural Killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection 105
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. 105
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 104
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia 104
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis 104
NK cells: innate immunity against hematological malignancies? 104
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 103
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 102
It's only innate immunity but I like it 102
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 101
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. 101
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 101
Human NK cells directly recognize Mycobacterium Bovis and acquire the ability to interact with monocyte-derived DC 99
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma 99
Natural killer cells in HIV-Infectious: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. 98
NK-DC interaction: On the usefulness of auto-aggression 98
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection 98
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 96
Monoclonal Antibodies against NKG2A 95
Cognate HLA absence in trans diminishes human NK cell education 95
The NK/DC complot 94
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. 93
Monoclonal Antibodies against NKG2A 93
Editorial: NK Cell Subsets in Health and Disease: New Developments 93
Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. 90
Human NK cells directly recognize Mycobacterium bovis and acquire the ability to interact with monocyte-derived DC 90
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 90
Monoclonal Antibodies against NKG2A 89
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines. Regulation by KIR/HLA-class I interaction. 89
Receptor-mediated regulation of human NK cells homing 88
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. 87
The Chem23 receptor for chemerin is expressed in CD56dim, CD16neg NK human cells 86
Monoclonal Antibodies against NKG2A 86
Dysregulation of regulatory CD56 (bright) NK cells/T cells interactions in multiple sclerosis 85
Monoclonal Antibodies against NKG2A 84
IL-12 or IL-4 prime human natural killer cells to mediate functionally divergent interactions with dendritic cells or tumors 84
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts. 84
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 84
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 84
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 84
Totale 11.295
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.948
article - articoli 39.870
book - libri 412
conference - conferenze 5.363
curatela - curatele 0
other - altro 311
patent - brevetti 3.415
selected - selezionate 0
volume - volumi 1.577
Totale 101.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.471 0 0 0 0 340 468 655 285 409 726 456 132
2020/20211.405 96 114 80 96 53 233 44 113 119 217 105 135
2021/20222.122 77 160 151 183 116 118 142 495 156 186 95 243
2022/20232.047 238 154 23 194 297 348 4 178 381 21 178 31
2023/20241.164 63 177 34 136 93 122 80 125 69 48 80 137
2024/2025998 76 260 133 229 300 0 0 0 0 0 0 0
Totale 16.155